Transparency and Disclosure

As a member of Medicines Australia (MA), Roche’s pharmaceutical division is committed to being open and transparent when we provide a reportable payment or transfer of value to a healthcare professional.

This includes the transparent disclosure of:

• Payments and benefits to healthcare professionals for provision of expert services (e.g. giving a lecture, chairing an educational meeting, providing advice as part of an Advisory Board or as a Consultant); Airfares, accommodation and/or conference registration fees to attend medical education events.

• sponsorship of independently organised Third Party Educational Meetings and Symposia with the purpose of enhancing medical knowledge and the quality use of medicines

• the nature of our relationships with Health Consumer Organisations where financial support, or significant direct or indirect non-financial support, has been provided.

For more information about the MA Code and reporting requirements, visit the

Healthcare professionals listed in Roche’s reports can request further information by contacting

• For reports of payments and transfers of value made to healthcare professionals, visit the

• For Third Party Meeting Sponsorship reports, visit the MA website forandreports.

• For Health Consumer Organisation Support reports, visit the MA website forandreports.

Notes:

Reportable payments made to healthcare professionals are detailed in six-monthly reports, in accordance with MA Code of Conduct, Roche Privacy Policy and the Australian Privacy Act 1988 (Cth). Prior to publication, each healthcare professional listed in the reports is afforded the opportunity to verify information. Data will be publicly available on the websites listed above for three years from the date of publication. To comply with the Australian Privacy Act 1988 (Cth), reports may be amended from time to time.